| Website | viapharmaceutical... |
| Category | BioTech |
| Employees | |
| Description | treatment of cardiovascular diseases |
| DEBT TOTAL | $10M |
| Debt, 3/09 Bay City Capital | $10M |
VIA Pharmaceuticals is a biotechnology company focused on the treatment of cardiovascular disease.VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need – reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke.
